Skip to main content
60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.600
-0.020 (-1.23%)
At close: Apr 28, 2026, 4:00 PM EDT
1.630
+0.030 (1.85%)
After-hours: Apr 28, 2026, 5:30 PM EDT

SXTP Revenue

In the year 2025, 60 Degrees Pharmaceuticals had annual revenue of $1.41M with 106.81% growth. 60 Degrees Pharmaceuticals had revenue of $316.38K in the quarter ending December 31, 2025, with 16.22% growth.

Revenue (ttm)
$1.41M
Revenue Growth
+106.81%
P/S Ratio
3.03
Revenue / Employee
$469,698
Employees
3
Market Cap
4.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.41M727.75K106.81%
Dec 31, 2024681.35K427.77K168.70%
Dec 31, 2023253.57K-257.64K-50.40%
Dec 31, 2022511.21K-5.84M-91.95%
Dec 31, 20216.35M3.80M149.18%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ensysce Biosciences 5.07M
SciSparc 1.31M
VivoSim Labs 142.00K
AIM ImmunoTech 88.00K
Pulmatrix 3.00K
Revenue Rankings

SXTP News

More News